FourThought Financial’s Genmab GMAB Stock Holding History

FourThought Financial’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$39K	Buy	1,227 +408	+50%	+$14.3K	0.01%	674
2022 Q2	$27K	Buy	819 +53	+7%	+$1.72K	﹤0.01%	794
2022 Q1	$28K	Sell	766 -18	-2%	-$618	﹤0.01%	820
2021 Q4	$31K	Sell	784 -9,724	-93%	-$405K	﹤0.01%	816
2021 Q3	$459K	Buy	10,508 +1,593	+18%	+$71.5K	0.06%	215
2021 Q2	$363K	Buy	8,915 +4,565	+105%	+$176K	0.05%	258
2021 Q1	$142K	Buy	4,350 +541	+14%	+$20.3K	0.02%	417
2020 Q4	$154K	Buy	+3,809	New	+$142K	0.02%	384

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FourThought Financial's GMAB Position: Q3 2022 in Review

FourThought Financial increased its Genmab (GMAB) stake by 50% in Q3 2022, buying an estimated $14.3K and bringing the position to 1,227 shares worth $39K. The position accounts for 0.01% of the portfolio, ranked #674.

FourThought Financial first reported a position in GMAB in Q4 2020 and has held it in 8 quarters since. The position peaked at $459K in Q3 2021. 194 funds tracked by Wall St. Rank hold GMAB as of Q3 2022.

FourThought Financial held 1,227 shares of Genmab worth $39K as of Q3 2022.
FourThought Financial bought 408 Genmab shares in Q3 2022, an estimated $14.3K.
Genmab made up 0.01% of FourThought Financial's portfolio in Q3 2022, its #674 holding.
FourThought Financial first reported a position in Genmab in Q4 2020 and has held it in 8 quarters since.
FourThought Financial's Genmab position peaked at $459K in Q3 2021.
194 funds tracked by Wall St. Rank held Genmab as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.